Seinäjoen keskussairaala

Julkaisut 2008
Publications 2008

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alatalo P et al. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers.
2 Alatalo PI et al. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index.
3 Barengo N et al. The diabetes-cardiovascular risk paradox:results from a Finnish population-based prospective study.
4 Bidel S et al. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes.
5 Bootorabi F et al. Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity.
6 Chen WM et al. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.
7 Dienert HC et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the prevention regimen for ...(ProFESS) strial.
8 Eräranta A et al. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
9 Eskelinen MH et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study.
10 Flinck A, Paavilainen E. Lasten kaltoinkohtelun tunnistaminen ja siihen puuttuminen on myös terveydenhuollon asia.
11 Flinck A, Paavilainen E. Violent Behavior of Men in Their Intimate Relationships, as They Experience It.
12 Flinck A et al. Intimate partner violence as experienced by men.
13 Färkkilä M et al. Serological markers for monitoring disease progression in noncirrhotic promary biliary cirrhosis on ursodeoxycholic acid therapy.
14 Gao W et al. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose.
15 Garren H et al. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.
16 Gaulton KJ et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes.
17 Harjutsalo V et al. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study.
18 Haukilahti R-L et al. Miten lääkärit ovat kokeneet työtahdin muuttuneen työssäoloaikanaan?
19 Haukilahti R-L et al. Lääkäri 2003 -tutkimus. Muuttuuko lääkärin työ - ja mihin suuntaan?
20 Haukilahti RL et al. Enemmistö lääkäreistä pitää tietoteknologian muutosta myönteisenä.
21 Helminen M et al. IL-10 gene polymorphism at -1082 A/G is associated with severe rhinovirus bronchiolitis in infants.
22 Hietala J et al. Alkoholisairauksien tutkiminen laboratoriokokein .
23 Honkanen P et al. Keuhkokuumeen hoito. Käypä hoito-suositus.
24 Hopia H et al. Havainnointi aineistonkeruumenetelmänä perhehoitotieteellisessä tutkimuksessä.
25 Hu G et al. Total cholesterol and the risk of Parkinson disease.
26 Hu G et al. The increasing prevalence of metabolic syndrome among Finnish men and women over a decade.
27 Hu G et al. Joint effects of coffee concumption and serum gammaglutamyltransferase on the risk of liver cancer.
28 Huuhka K et al. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
29 Hyppölä H et al. Sattumaa vai harkintaa - lääkärien erikoisalavalintaan vaikuttavat tekijät.
30 Joronen K et al. Perhehoitotyön toteutumista arvioivat mittarit - systemoitu katsaus.
31 Järvinen TM et al. A population-specific diabetogenic haplotype HLA-A2,Cw1,B56,DR4,DQ8 is associated with high birthweight in Finnish diabetic families.
32 Kalliokoski T et al. Pancreatic glucose uptake in vivo in men with newly diagnosed type 1 diabetes.
33 Kankaanranta T et al. Kunnalliselle vai yksityiselle? Pelkästään taloudelliset tekijät eivät ohjaa lääkärien työpaikan valintaa.
34 Karavalakis E et al. Paricalcitol treatment and arterial tone in experimental renal insufficiency.
35 Karjalainen J et al. Leisure time physical activity in individuals with screen-detected type 2 diabetes compared to those with known type 2 diabetes.
36 Kilpeläinen TO et al. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome. The Finnish Diabetes Prevention Study.
37 Kilpeläinen TO et al. SNPs in PPARG associate with type 2 diabetes and interact with physical activity.
38 Kivipelto M et al. Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study.
39 Kjeldsen SE et al. Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial.
40 Koivisto H et al. Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.
41 Konsti J et al. A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals.
42 Korpi-Hyövälti E, Linjama H. Kansalliset tilastot eivät kerro koko totuutta lasten lihavuudesta.
43 Kristjansdottir G et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations.
44 Kujala J et al. Simultaneous bilateral stapes surgery.
45 Kuoppamäki R. Ammattikorkeakoulun erikoistumisopinnot asiantuntijuuden kehittäjänä.
46 Laitio RM et al. Bispectral index, entropy, and quantitative electroencephalogram during single-agent xenon anesthesia.
47 Lehtonen A et al. Serum testosterone but not leptin predis mortality in elderly men.
48 Leipälä JA et al. Viilennyksen vaikuttavuus ja turvallisuus vastasyntyneen hypoksis-iskeemisen enkefalopatian hoidossa.
49 Lepistö A et al. Overlapr technique improves results of primary surgery after obstetric anal sphincter tear.
50 Mager U et al. Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
51 Mayer SA et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
52 Myllärniemi M et al. Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype.
53 Mäenpää T et al. Kouluterveydenhuolto ja alakoulun oppilas - terveydenhoitajien näkemyksiä yhteistyöstä.
54 Mäkelä R et al. The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.
55 Mäkinen T. The Finnish population-based prostate cancer screening trial.
56 Mäkinen T et al. Assessment of causes of death in a prostate cancer screening trial.
57 Mäkinen VP et al. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.
58 Mäkiniemi E et al. Riskitekijöiden vertailu olkavarren ja kyynärvarren pienienergiaisissa murtumissa.
59 Nan H et al. Serum uric acid and incident diabetes in Mauritian Indian and Creole populations.
60 Nieminen K et al. Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh.
61 Nikus K et al. ST-nousuinfarktin hoidossa on vielä parantamisen varaa. Tutkimus neljän sairaanhoitopiirin hoitokäytännöistä.
62 Paavola T. Exploring IT system benefits in health care.
63 Parkkonen J et al. Phosphodiesterase 4 inhibitors delay human eosinophil and neutrophil apoptosis in the absence and presence of salbutamol.
64 Perttunen H et al. Beta2-agonists potentiate corticosteroid-induced neutrophil survival.
65 Polman C et al. Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b.
66 Raitanen M et al. Pinnallinen virtsarakkosyöpä.
67 Raitanen M-P et al. The role of BTA stat test in follow-up of patients with bladder cancer: results from FinnBladder studies.
68 Rosti-Otajärvi E et al. The reliability of the MSFC and its components.
69 Saal LH et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
70 Saaristo T et al. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population.
71 Sacco RL et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
72 Salminen-Tuomaala M et al. Potilaan saattajien ohjauksen tarve päivystyspoliklinikalla.
73 Salonen AJ et al. Finnish multicenter study comparing intermittent to continuous androgen deprivation for advanced prostate cancer: interim analysis of prognostic markers affecting initial response to androgen deprivation.
74 Sankelo M, Akerblad L. Nurse entrepreneurs' attitudes to management, their adoption of the manager's role and managerial assertiveness.
75 Saraheimo M et al. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
76 Schmieder RE et al. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
77 Schwarz PE et al. The European perspective of type 2 diabetes prevention: diabetes in Europe--prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
78 Sepponen A et al. Alveolar and bronchial nitric oxide output in healthy children.
79 Sonkajärvi E et al. Burst suppression during propofol anaesthesia recorded from scalp and subthalamic electrodes: report of three cases.
80 Sumanen M et al. Use of quality improvement methods in Finnish health centres in 1998 and 2003.
81 Suomal.lääkäriseuran Duodecim. ja Suomen Psyk.yhd.asett.työr., Et AL. Kaksisuuntainen mielialahäiriö. Käypä hoito-suositus.
82 Suoyrjö H et al. Effects of multidisciplinary inpatient rehabilitation for chronic back or neck pain: a register-linkage study of sickness absences and analgesic purchases in an occupational cohort.
83 Tamminen K et al. Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*.
84 Tuomilehto H et al. Sleep-disordered breathing is related to an increased risk for type 2 diabetes in middle-aged men, but not in women--the FIN-D2D survey.
85 Tuomilehto H et al. Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women – The FIN-D2D survey.
86 Tuomilehto J et al. Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy.
87 Tuomisto L et al. Asthma programme in Finland: the quality of primary care spirometry is good.
88 Vaarala MH et al. Retrospective analysis of long-term outcomes of 64 patients treated by endopyelotomy in two low-volume hospitals: good and durable results.
89 Vainionpää A et al. Piinaava reisikipu.
90 Vidali M et al. Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-alpha in heavy drinkers.
91 Väistö O et al. Anterior knee pain after intramedullary nailing of fractures of the tibial shaft: an eight-year follow-up of a prospective, randomized study comparing two different nail-insertion techniques.
92 Warnakulasuriya S et al. Demonstration of ethanol-induced protein adducts in oral leukoplacia (pre-cancer) and cancer.
93 Yusuf S et al. Termisartan to prevent recurrent stroke and cardiovascular events.
94 Zeggini E et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
Julkaisutietokanta 26.11.2009 Publications Data Base 26.11.2009